Drug Profile
SARS-CoV-2 vaccine - EpiVax/University of Georgia
Alternative Names: COVID-19 vaccineLatest Information Update: 20 Jan 2022
Price :
$50
*
At a glance
- Originator EpiVax; University of Georgia
- Class COVID-19 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research COVID 2019 infections